Impact Factor
3.44
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.84
789 total citations
h5-index
36
h5 depth signal
Cited share
64.3%
189 of 294
Total citations
789
Citation footprint
Metric signal
3.25
External metric anchor
Self-citation
2.4%
19 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Portugal
327
Italy
166
Spain
93
China
87
Brazil
71
Citing Fields of Research
Respiratory Support
307
Allergies
219
Lung Cancer
165
Auto-Inflammatory Disorders
86
Mycobacterial Diseases
77
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,195
Articles tracked across the journal lifetime
Indexed publication set
294
189 cited publications
Last 12 months
140
11.7 publications/month
Open access share
100.0%
140 OA publications in the last year
Leading citing country
Portugal
327 citing publications
Leading citing field
Respiratory Support
307 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v24n1, Jan./Feb. 2018-
v24n1, Jan./Feb. 2018-
Research Focus & Classification
Indexed Subjects
Allergies
Respiratory Support
Lung Cancer
Chronobiology
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
issuing body
Sociedade Portuguesa de Pneumologia
Broad Categories
Pulmonary Medicine
Allergies
Auto-Inflammatory Disorders
Lung Cancer
Respiratory Support
Virology
MeSH Descriptors
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/25310429.2026.2748138
Open DOI
Correspondence on “ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation” by García-Rodríguez et al
To the Editor,García-Rodríguez et al. provide a valuable investigation into the relationship between alpha-1 antitrypsin (AAT) genotype, sex, and lung cancer (LC) characteristics.1 We commend the a...
02
03
DOI 10.1080/25310429.2026.2739160
Open DOI
Letter to editor ‘Cost comparison of UniAMP with Truenat for tuberculosis detection in India’
Dear Editor,We read with interest the study by Muniyandi et al. comparing the costs and diagnostic outcomes of UniAMP and Truenat for tuberculosis (TB) detection in India,1 and it addressed an impo...
04
DOI 10.1080/25310429.2026.2743959
Open DOI
Stable lung function, but how stable? Methodological and clinical questions in defining asthma remission
Dear Editor,We read with great interest the article by Tiotiu et al., ‘Defining lung function in asthma remission: Results of an international Delphi study’.1 The authors address an increasingly im...
05
DOI 10.1080/25310429.2026.2742748
Open DOI
Monitoring symptoms and performance in rehabilitation: Can we detect COPD exacerbation?
06
DOI 10.1080/25310429.2026.2742798
Open DOI
Health utilities in individuals with alpha-1 antitrypsin deficiency with and without COPD from the EARCO registry
Alpha-1 antitrypsin deficiency (AATD) is a rare, autosomal codominant inherited disorder characterised by low serum levels of alpha-1 antitrypsin (AAT), a protease inhibitor primarily produced in t...
07
08
09
10
DOI 10.1080/25310429.2026.2742051
Open DOI
A pilot study to assess the role of 12-week roflumilast treatment in non-CF bronchiectasis
The classical airway inflammation in non-cystic fibrosis (CF) bronchiectasis consists of neutrophilic infiltration.1–4 The recruitment and trafficking of neutrophils to bronchiectatic airways are m...
Bibliographical & Catalog Notes
Some volumes contain special issues.
Official journal of the Portuguese Society of Pulmonology (Sociedade Portuguesa de Pneumologia/SPP).